Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction

被引:8
|
作者
Habba, Saad F. [1 ,2 ]
机构
[1] Overlook Hosp Atlantic Hlth Syst, Summit, NJ 07901 USA
[2] Mt Sinai Sch Med, New York, NY USA
关键词
BILE-ACID MALABSORPTION; EPIDEMIOLOGY; POPULATION; PREVALENCE; SYMPTOMS;
D O I
10.1016/j.mehy.2010.08.040
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Diarrhea Predominant Irritable Bowel Syndrome IBS (IBS-D) and functional diarrhea constitute 50% of cases treated by gastroenterology specialists and a significant proportion of those treated in a primary physicians practice. The size of the problem and the difficulty in successfully addressing these entities has frustrated patients and physicians alike. The presented data delineates work-up, final diagnoses and clinical outcomes in the largest single clinical retrospective study of 303 patients with an initial presentation of IBS-D and functional diarrhea. Results indicate that 298 (98%) patients were found to have a diagnosis different from the initial presentation of IBS-D, and 204 (68%) of the patients studied had conditions related to treatable bile acid abnormalities. After identifying these clinical diagnoses and instituting appropriate therapy, 98% of these patients had a favorable response, as measured by a decrease in the number of bowel movements to less than three per day and a significant change in the consistency of the stools. This finding is dramatically different from the poor response generally experienced from conventional therapy for IBS-D and functional chronic diarrhea. The data presented in this study substantiates the hypothesis that IBS-D and functional diarrhea do not exist as true clinical entities and explains the previous lack of satisfactory therapeutic response. Symptoms experienced by these patients were caused by a collection of different clinical conditions bunched up under this "umbrella" diagnosis of IBS-D. Once these separate entities were identified and appropriately addressed, the clinical response was quite impressive and encouraging. The implication of this hypothesis could be of vital importance because of the number of those suffering from these symptoms. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:97 / 99
页数:3
相关论文
共 50 条
  • [1] Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 858 - 858
  • [2] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [3] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [4] INCLUSION OF A NOVEL IBS BLOOD PANEL FOR DIAGNOSING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): A UK PERSPECTIVE
    Soubieres, A.
    Pimentel, M.
    Purdy, C.
    Magar, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A350 - A350
  • [5] AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Carrasco-Labra, Alonso
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    Surawicz, Christina M.
    Chey, William D.
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 859 - 880
  • [6] Red chili aggravates postprandial gastrointestinal symptoms in diarrhea predominant irritable bowel syndrome (IBS-D) patients
    Geratikornsupuk, Nopavut
    Mahayosnond, Atchara
    Gonlachanvit, Sutep
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 : 62 - 62
  • [7] Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
    Xu, Xiao-juan
    Liu, Liang
    Yao, Shu-kun
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (01): : 1 - 9
  • [8] Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
    Breslin, Henry J.
    Diamond, Craig J.
    Kavash, Robert W.
    Cai, Chaozhong
    Dyatkin, Alexey B.
    Miskowski, Tamara A.
    Zhang, Sui-Po
    Wade, Paul R.
    Hornby, Pamela J.
    He, Wei
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4869 - 4872
  • [9] The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)
    Min, Yang Won
    Rhee, Poong-Lyul
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (03) : 136 - 142
  • [10] Burden of Disease in US Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
    Lacy, Brian E.
    Xu, Yanqing
    Taylor, Douglas C.
    Kosch, Katherine J.
    Dobrescu, Rachel
    Morlock, Amy
    Morlock, Robert
    Rooker, Ceciel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S399 - S400